Brown Miller Wealth Management LLC Buys Shares of 2,712 The Clorox Company (NYSE:CLX)

Brown Miller Wealth Management LLC bought a new position in The Clorox Company (NYSE:CLX - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 2,712 shares of the company's stock, valued at approximately $399,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CLX. Norges Bank purchased a new stake in Clorox during the 4th quarter worth $259,041,000. FMR LLC lifted its stake in shares of Clorox by 75.4% during the fourth quarter. FMR LLC now owns 1,361,758 shares of the company's stock worth $221,163,000 after purchasing an additional 585,526 shares in the last quarter. Marshall Wace LLP boosted its position in shares of Clorox by 549.8% in the fourth quarter. Marshall Wace LLP now owns 542,726 shares of the company's stock worth $88,144,000 after buying an additional 459,203 shares during the period. ExodusPoint Capital Management LP grew its stake in shares of Clorox by 187.9% in the fourth quarter. ExodusPoint Capital Management LP now owns 698,900 shares of the company's stock valued at $113,508,000 after buying an additional 456,114 shares in the last quarter. Finally, Man Group plc raised its holdings in shares of Clorox by 154.6% during the 4th quarter. Man Group plc now owns 570,503 shares of the company's stock valued at $92,655,000 after buying an additional 346,449 shares during the period. Institutional investors and hedge funds own 78.53% of the company's stock.

Clorox Stock Performance

Shares of CLX stock traded down $1.33 on Thursday, hitting $120.77. 1,724,088 shares of the stock traded hands, compared to its average volume of 1,363,794. The company has a market capitalization of $14.88 billion, a PE ratio of 21.68, a PEG ratio of 2.76 and a beta of 0.54. The company's fifty day moving average is $133.92 and its 200 day moving average is $147.55. The company has a debt-to-equity ratio of 13.07, a current ratio of 0.74 and a quick ratio of 0.44. The Clorox Company has a 1-year low of $120.69 and a 1-year high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). Clorox had a return on equity of 324.23% and a net margin of 9.89%. The business had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.74 billion. During the same quarter in the previous year, the business posted $1.71 earnings per share. The company's quarterly revenue was down 8.0% compared to the same quarter last year. On average, equities research analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

CLX has been the topic of a number of recent research reports. Evercore ISI set a $140.00 target price on shares of Clorox and gave the stock an "underperform" rating in a research report on Tuesday, May 6th. UBS Group decreased their price objective on shares of Clorox from $176.00 to $154.00 and set a "neutral" rating for the company in a research report on Thursday, April 17th. Citigroup dropped their target price on Clorox from $165.00 to $150.00 and set a "neutral" rating on the stock in a research report on Monday, April 14th. Morgan Stanley cut their price target on Clorox from $165.00 to $150.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 6th. Finally, Barclays lowered their price objective on Clorox from $134.00 to $129.00 and set an "underweight" rating for the company in a research note on Wednesday, May 7th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $151.23.

Insider Activity

In related news, Director Pierre R. Breber acquired 4,000 shares of Clorox stock in a transaction that occurred on Wednesday, May 7th. The stock was acquired at an average price of $136.57 per share, for a total transaction of $546,280.00. Following the transaction, the director now directly owns 4,000 shares of the company's stock, valued at $546,280. This trade represents a ∞ increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.57% of the company's stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.